News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Alison Little, Bill Shew

Advertisement

Articles by Alison Little, Bill Shew

Ten integrated imperatives for pharma commercial transformation

ByAlison Little, Bill Shew,Peter Gilmore, KPMG LLP
August 25th 2015

The pharma industry needs to go farther in adapting to new marketplace realities

Advertisement

Latest Updated Articles

  • Ten integrated imperatives for pharma commercial transformation
    Ten integrated imperatives for pharma commercial transformation

    Published: August 25th 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

2

Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies

3

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

4

Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

5

Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us